The monoglycosylated recombinant hemagglutinin protein vaccine and monoglycosylated influenza split virus vaccine are effective vaccines with cross-protection against H1N1 virus infections in mouse and ferret model
博士 === 國防醫學院 === 生命科學研究所 === 105 === Each year influenza virus infections cause hundreds of thousands of deaths worldwide and a significant level of morbidity with great economic loss. Vaccination of the trivalent or quadrivalent inactivated virus vaccine produced from embryonated chicken eggs is at...
Main Authors: | Yung-Chieh Tseng, 曾勇傑 |
---|---|
Other Authors: | Che Ma |
Format: | Others |
Language: | en_US |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/09273145611452145495 |
Similar Items
-
The Monoglycosylated Hemagglutinin from Seasonal Influenza H1N1 Is an Effective Vaccine with CrossProtective Immunity against Pandemic 2009 H1N1 Virus Infection in Mice
by: Juine-Ruey Chen, et al.
Published: (2010) -
Biotransformation of quercetin, kaempferol and apigenin to monoglycosylated derivatives by in vitro suspension cultures of Astragalus vesicarius ssp. carniolicus
by: Pavlinka Popova, et al.
Published: (2021-04-01) -
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
by: Meagan McMahon, et al.
Published: (2019-08-01) -
Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
by: Jenny E. Hernandez-Davies, et al.
Published: (2021-07-01) -
Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
by: Daniel Stadlbauer, et al.
Published: (2017-12-01)